The most recent guidance for Catalyst Pharmaceuticals (CPRX) was reported on February 25, 2026 for the fiscal year 2026. Catalyst Pharmaceuticals forecasted revenue between $615.00M and $645.00M for the period.

Catalyst Pharmaceuticals (CPRX) guided revenue in the range of $615.00M to $645.00M for the fiscal year 2026.

Catalyst Pharmaceuticals (CPRX) raised its revenue guidance from a prior range of $565.00M - $585.00M to $615.00M - $645.00M for the fiscal year 2026.

Catalyst Pharmaceuticals (CPRX) last issued guidance on February 25, 2026 for the fiscal year 2026.